These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38957862)

  • 1. HCV prevalence and phylogenetic characteristics in a cross-sectional, community study of young people who inject drugs in New York City: Opportunity for and threats to HCV elimination.
    Pedro MG; Seanna P; Honoria G; Renee H; Chunki F; Ben E
    Health Sci Rep; 2024 Jul; 7(7):e2211. PubMed ID: 38957862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus risk among young people who inject drugs.
    Mateu-Gelabert P; Sabounchi NS; Guarino H; Ciervo C; Joseph K; Eckhardt BJ; Fong C; Kapadia SN; Huang TTK
    Front Public Health; 2022; 10():835836. PubMed ID: 35968435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.
    Tieu HV; Laeyendecker O; Nandi V; Rose R; Fernandez R; Lynch B; Hoover DR; Frye V; Koblin BA
    PLoS One; 2018; 13(7):e0200269. PubMed ID: 30020960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.
    Yi S; Mun P; Chhoun P; Chann N; Tuot S; Mburu G
    Harm Reduct J; 2019 Apr; 16(1):29. PubMed ID: 31036011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
    Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
    Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico.
    Aponte-Meléndez Y; Eckhardt B; Fong C; Padilla A; Trinidad-Martínez W; Maldonado-Rodríguez E; Agront N; Mateu-Gelabert P
    J Subst Use Addict Treat; 2024 May; 160():209308. PubMed ID: 38301921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C testing and treatment uptake among young people who use opioids in New York City: A cross-sectional study.
    Kapadia SN; Katzman C; Fong C; Eckhardt BJ; Guarino H; Mateu-Gelabert P
    J Viral Hepat; 2021 Feb; 28(2):326-333. PubMed ID: 33141503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
    Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
    Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
    Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
    Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndemic factors associated with non-fatal overdose among young opioid users in New York City.
    Guarino H; Frank D; Quinn K; Kim D; Gile K; Ruggles K; Friedman SR; Mateu-Gelabert P
    Front Public Health; 2023; 11():1195657. PubMed ID: 37435512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
    Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J;
    Int J Drug Policy; 2022 Jul; 105():103706. PubMed ID: 35533635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
    Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
    Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities.
    Estadt AT; Miller WC; Kline D; Whitney BM; Young AM; Todd Korthuis P; Stopka TJ; Feinberg J; Zule WA; Pho MT; Friedmann PD; Westergaard RP; Eagen KV; Seaman A; Ma J; Go VF; Lancaster KE
    Int J Drug Policy; 2023 Oct; ():104222. PubMed ID: 37806839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.
    Patel EU; Solomon SS; Lucas GM; McFall AM; Tomori C; Srikrishnan AK; Kumar MS; Laeyendecker O; Celentano DD; Thomas DL; Quinn TC; Mehta SH
    Int J Drug Policy; 2021 Oct; 96():103354. PubMed ID: 34247900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot.
    Carrington N; Conway A; Grebely J; Starr M; Catlett B; Stevens A; Prain B; McGrath C; Causer L; Guy R; Holden J; Keen P; Kingsland M; Lu H; Power C; Read P; Murray C; McNulty A; Cunningham P;
    BMC Infect Dis; 2024 Jan; 24(1):137. PubMed ID: 38287234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.
    Khezri M; Mirzazadeh A; Shokoohi M; Sharafi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mousavian G; Imani M; Kakavand-Ghalehnoei R; Komasi A; Gouya MM; Haghdoost AA; McFarland W; Karamouzian M; Sharifi H
    Drug Alcohol Depend; 2023 Feb; 243():109751. PubMed ID: 36621200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.